KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation https://www.biorxiv.org/content/10.1101/2022.11.17.516956v1?med=mas
KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation https://www.biorxiv.org/content/10.1101/2022.11.17.516956v1?med=mas